regulatory guideline [Regulatives / Guidelines]

posted by wock – India, 2023-05-22 08:06 (6 d 13:43 ago) – Posting: # 23563
Views: 149

In bioequivalence study if any adverse event is ongoing; we can collect safety sample or end study sample before completion of adverse event. if any reference guideline pls show

Complete thread:

UA Flag
Activity
 Admin contact
22,614 posts in 4,740 threads, 1,609 registered users;
22 visitors (0 registered, 22 guests [including 11 identified bots]).
Forum time: 21:50 CEST (Europe/Vienna)

For every fact
there is an infinity of hypotheses.    Robert M. Pirsig

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5